1. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis. (1st May 2019) Authors: Yosipovitch, G.; Reaney, M.; Mastey, V.; Eckert, L.; Abbé, A.; Nelson, L.; Clark, M.; Williams, N.; Chen, Z.; Ardeleanu, M.; Akinlade, B.; Graham, N.M.H.; Pirozzi, G.; Staudinger, H.; Plaum, S.; Radin, A.; Gadkari, A. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS). (1st December 2019) Authors: Wollenberg, A.; Beck, L.A.; Blauvelt, A.; Simpson, E.L.; Chen, Z.; Chen, Q.; Shumel, B.; Khokhar, F.A.; Hultsch, T.; Rizova, E.; Rossi, A.B.; Graham, N.M.H.; Pirozzi, G.; Lu, Y.; Ardeleanu, M. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to R. Waldman et al.: 'Does IL‐4 inhibition play a role in dupilumab‐associated conjunctivitis?'. (9th February 2020) Authors: Ardeleanu, M.; Shumel, B.; Rossi, A.B.; Graham, N.M.H. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A study of dupilumab in the treatment of adolescents with eczema. (2nd January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 一项关于 dupilumab 治疗湿疹青少年患者的研究. (2nd January 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension. (8th October 2019) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Hultsch, T.; Davis, J.D.; Zhang, Y.; Zhu, X.; Chen, Z.; Li, M.; Ardeleanu, M.; Teper, A.; Akinlade, B.; Gadkari, A.; Eckert, L.; Kamal, M.A.; Ruddy, M.; Graham, N.M.H.; Pirozzi, G.; Stahl, N. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open‐label phase IIa study and subsequent phase III open‐label extension study. (9th October 2020) Authors: Cork, M.J.; Thaçi, D.; Eichenfield, L.F.; Arkwright, P.D.; Sun, X.; Chen, Z.; Akinlade, B.; Boklage, S.; Guillemin, I.; Kosloski, M.P.; Kamal, M.A.; O'Malley, J.T.; Patel, N.; Graham, N.M.H.; Bansal, A. Journal: British journal of dermatology Issue: Volume 184:Number 5(2021) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Validation of the Peak Pruritus Numerical Rating Scale. (1st October 2019) Authors: Yosipovitch, G.; Reaney, M.; Mastey, V.; Eckert, L.; Abbé, A.; Nelson, L.; Clark, M.; Williams, N.; Chen, Z.; Ardeleanu, M.; Akinlade, B.; Graham, N.M.H.; Pirozzi, G.; Staudinger, H.; Plaum, S.; Radin, A.; Gadkari, A. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: e94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 峰值瘙痒数字评价量表的验证. (1st October 2019) Authors: Yosipovitch, G.; Reaney, M.; Mastey, V.; Eckert, L.; Abbé, A.; Nelson, L.; Clark, M.; Williams, N.; Chen, Z.; Ardeleanu, M.; Akinlade, B.; Graham, N.M.H.; Pirozzi, G.; Staudinger, H.; Plaum, S.; Radin, A.; Gadkari, A. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis. (1st October 2019) Authors: Yosipovitch, G.; Reaney, M.; Mastey, V.; Eckert, L.; Abbé, A.; Nelson, L.; Clark, M.; Williams, N.; Chen, Z.; Ardeleanu, M.; Akinlade, B.; Graham, N.M.H.; Pirozzi, G.; Staudinger, H.; Plaum, S.; Radin, A.; Gadkari, A. Journal: British journal of dermatology Issue: Volume 181:Number 4(2019) Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗